ChemicalBook > CAS DataBase List > 1,5-Bis[(E)-2-(3,4-dichlorophenyl)vinyl]-2,4-dinitrobenzene
1,5-Bis[(E)-2-(3,4-dichlorophenyl)vinyl]-2,4-dinitrobenzene
- Product Name
- 1,5-Bis[(E)-2-(3,4-dichlorophenyl)vinyl]-2,4-dinitrobenzene
- CAS No.
- 1618672-71-1
- Chemical Name
- 1,5-Bis[(E)-2-(3,4-dichlorophenyl)vinyl]-2,4-dinitrobenzene
- Synonyms
- NSC 636819;KDM4A/KDM4B Inhibitor, NSC636819;1,5-Bis[(E)-2-(3,4-dichlorophenyl)vinyl]-2,4-dinitrobenzene;1,5-Bis[(1E)-2-(3,4-dichlorophenyl)ethenyl]-2,4-dinitrobenzene;Benzene, 1,5-bis[(1E)-2-(3,4-dichlorophenyl)ethenyl]-2,4-dinitro-
- CBNumber
- CB63372281
- Molecular Formula
- C22H12Cl4N2O4
- Formula Weight
- 510.15
- MOL File
- 1618672-71-1.mol
More
Less
1,5-Bis[(E)-2-(3,4-dichlorophenyl)vinyl]-2,4-dinitrobenzene Property
- Boiling point:
- 625.5±55.0 °C(Predicted)
- Density
- 1.558±0.06 g/cm3(Predicted)
- storage temp.
- Store at -20°C
- solubility
- Soluble in DMSO
- form
- Solid
- color
- Yellow to orange
More
Less
N-Bromosuccinimide Price
Tocris
- Product number
- 5287
- Product name
- NSC636819
- Purity
- ≥98%(HPLC)
- Packaging
- 10
- Price
- $223
- Updated
- 2021/12/16
Tocris
- Product number
- 5287
- Product name
- NSC636819
- Purity
- ≥98%(HPLC)
- Packaging
- 50
- Price
- $934
- Updated
- 2021/12/16
TRC
- Product number
- N900543
- Product name
- NSC636819
- Packaging
- 50mg
- Price
- $800
- Updated
- 2021/12/16
TRC
- Product number
- N900543
- Product name
- NSC636819
- Packaging
- 5mg
- Price
- $120
- Updated
- 2021/12/16
TRC
- Product number
- N900543
- Product name
- NSC636819
- Packaging
- 10mg
- Price
- $195
- Updated
- 2021/12/16
More
Less
1,5-Bis[(E)-2-(3,4-dichlorophenyl)vinyl]-2,4-dinitrobenzene Chemical Properties,Usage,Production
Uses
NSC 636819 is a novel and selective KDM4A/KDM4B inhibitor that induces apoptosis in cultured prostate cancer cells.
Biological Activity
Cell permeable: yes', 'Primary Target
KDM4A/B', 'Reversible: yes
in vivo
NSC636819 (C-4) (20 or 40 mg/kg; ip; 5 times a week; 4 weeks) strongly suppresses A549 tumor growth and sensitizes tumors to TRAIL-inducer ONC201 in mouse model[2].
| Animal Model: | A549 Lung cancer xenograft model in mice[2] |
| Dosage: | 20 mg/kg, 40 mg/kg |
| Administration: | ip; 5 times per weeks, 27 days; with or without ONC201 (i.p.; 25?mg/kg, 1 time a week). |
| Result: | Dose-dependently inhibited the tumor growth, and sensitized tumors to TRAIL. Induced tumor expression of TRAIL, DR5 and the level of cleaved caspase-7 and H3K9me3, whereas decreased the expression of KDM4A in xenograft tumors. |
IC 50
KDM4
storage
Store at +4°C
1,5-Bis[(E)-2-(3,4-dichlorophenyl)vinyl]-2,4-dinitrobenzene Preparation Products And Raw materials
Raw materials
Preparation Products
More
Less